Records containing: Lupus
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2023-08-31Aerobic Exercise Versus Whole-Body Vibration On Fatigue, Functional Capacity And Quality Of Life In Patients With Systemic Lupus Erythematosus: A Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2022-11-18A Phase 2, Double-blind, Randomized, Placebo-controlled Multicenter Study to Evaluate Efficacy, Safety, and Tolerability of JBT-101 in Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2022-05-23Deployment o the Multidisciplinary Prospective Cohort Imminent
-
CLINICAL_TRIALS study record update · 2022-05-10Pilot Study Characterizing Aerobic Exercise in Women With Systemic Lupus Erythematosus (Exercise SLE Pilot).
-
CLINICAL_TRIALS study record update · 2021-01-06A Study to Determine the Pharmacokinetic Profile of BMS-986165 Administered as Various Solid Dispersion Tablet Formulations in Healthy Subjects
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2020-02-25An Open-Label, Single-Sequence Study to Investigate the Effects of BMS-986165 on the Single-Dose Pharmacokinetics of Methotrexate in Healthy Male Subjects
-
CLINICAL_TRIALS study record update · 2019-11-19Evaluation of MyoStrain™ in Clinical Practice
-
CLINICAL_TRIALS study record update · 2019-01-04A Phase 2, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Lulizumab Pegol vs. Placebo on a Background of Limited Standard of Care in the Treatment of Subjects With Active Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2018-06-28Lupus Interval Monitoring to Manage Disease Flare and Enable Treatment Optimization
-
CLINICAL_TRIALS study record update · 2018-05-09Predictors of Adaptation and a Cognitive Behavioral Intervention for African American Adolescents With Lupus
-
CLINICAL_TRIALS study record update · 2017-07-02Disease Progression and Activity in the Carolinas Lupus Study - MUSC Medical University of South Carolina Follow up
-
CLINICAL_TRIALS study record update · 2016-08-09A Phase 2A , Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Dose Study to Evaluate the Safety and Tolerability of Multiple Subcutaneous Doses of MEDI-545, A Fully Human Anti-Interferon-Alpha Monoclonal Antibody, In Subjects With Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2016-08-05Transcultural Validation in French of the Systemic Lupus Activity Questionnaire (SLAQ) and the Lupus Quality Of Life (LupusQoL) Questionnaire
-
CLINICAL_TRIALS study record update · 2014-09-16A Randomized, Double-blind, Placebo-controlled, Single Dose, Two-period, Crossover Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy of AMG 811 in Subjects With Discoid Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2014-04-25Effect of Vitamin D3 on the IFN Alpha Signature in Patients With Systemic Lupus Erythematosus (ALE02)
-
CLINICAL_TRIALS study record update · 2014-01-10A Randomized, Double-blind, Placebo-controlled, Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effect of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2013-12-24A Randomized Controlled Trial of Strategies for the Prevention of Accelerated Atherosclerosis in Systemic Lupus Erythematosus - A Pilot Study
-
CLINICAL_TRIALS study record update · 2012-07-11A Phase 1b, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Tolerability of Multiple Intravenous Doses of MEDI-545, a Fully Human Anti-Interferon-Alpha Monoclonal Antibody, in Patients With Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2010-08-11A Randomized Multicenter Trial Comparing Leflunomide and Azathioprine as Remission-Maintaining Treatment for Proliferative Lupus Glomerulonephritis.
-
CLINICAL_TRIALS study record update · 2008-01-07A Randomized, Double-Blind, Multi-Center, Placebo- Controlled Study to Assess Prevention of Bone Loss by Treatment With GL701 (Prestara) in Women With Systemic Lupus Erythematosus Receiving Treatment With Glucocorticoids
-
CLINICAL_TRIALS study record update · 2007-12-18A Phase I, Randomized, Double-Blind, Placebo Controlled, Dose-Escalation Study to Evaluate Safety and Tolerability of a Single IV Dose of MEDI-545, a Fully Human Monoclonal Antibody Directed Against Interferon Alpha Subtypes, in Patients With Systemic Lupus Erythematosus (SLE)